Cue Biopharma, Inc. Common Stock (CUE)

Typically moves ±10.59% on earnings
EARNINGS ANALYTICS
search

Across 8 earnings reports since May 09, 2024, Cue Biopharma, Inc. Common Stock (CUE) has a clear post-earnings pattern. It moves ±10.59% on average after reporting and finishes higher 0.0% of the time. Its largest post-earnings gain was -0.54% (May 12, 2025) and its largest decline was -17.55% (Nov 14, 2024).

Earnings reactions

How CUE moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

8

Avg Abs. Movement

±10.59%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 14, 2026 ☽ POST -16.99% open_in_new
Mar 16, 2026 ☽ POST -15.99% open_in_new
Nov 12, 2025 ☽ POST -7.17% open_in_new
Aug 12, 2025 ☽ POST -0.91% open_in_new
event

Earnings Count

8

Total earnings in dataset

trending_up

Avg Abs. Movement

±10.59%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 12 →
12
Funds holding
$3475197
Total value held
Buying
12 added · 0 reduced
Blackrock, Inc.
$1824389 NEW BUY
Ubs Group Ag
$842652 NEW BUY
Northern Trust Corp
$287890 NEW BUY
Stifel Financial Corp
$259360 NEW BUY
Bank Of America Corp /De/
$218680 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
4/A 20260828 open_in_new SEC.gov
4/A 20260828 open_in_new SEC.gov
SCHEDULE 13D 20260821 open_in_new SEC.gov
EFFECT 20260820 open_in_new SEC.gov
4 20260817 open_in_new SEC.gov
4 20260817 open_in_new SEC.gov
10-Q 20260814 open_in_new SEC.gov
144 20260814 open_in_new SEC.gov
4 20260814 open_in_new SEC.gov
8-K 20260814 open_in_new SEC.gov

Frequently asked about CUE earnings

How much does CUE stock move after earnings? expand_more

Over 8 reports, CUE has moved an average of ±10.59% the session after earnings, closing higher 0.0% of the time.

What was CUE's biggest post-earnings move? expand_more

CUE's largest post-earnings gain on record was -0.54% on May 12, 2025, and its largest decline was -17.55% on Nov 14, 2024.

Where can I find Cue Biopharma, Inc. Common Stock's SEC filings? expand_more

All of Cue Biopharma, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers